(HYDRA) Hydratec Industries - Ratings and Ratios
Fluid Systems, Food Tech, Health Tech
Description: HYDRA Hydratec Industries
Hydratec Industries NV is a diversified industrial company operating globally, with a presence in multiple regions including Europe, Asia, North America, South America, Africa, and Oceania. The company manufactures and supplies a wide range of industrial systems and plastic components to various markets, including food, health, and mobility.
The companys product portfolio includes sterilized product handling systems, automated packaging solutions, industrial incubators, hatchery automation systems, climate control equipment, and hatchery management software. Additionally, it produces extrusion equipment for PVC pipes and plastic injection molding products for various applications, including climate control systems, automotive, and medical devices.
To further analyze Hydratec Industries NV, we can examine key performance indicators (KPIs) such as revenue growth, operating margin, and return on equity (RoE). With a RoE of 33.66%, the company demonstrates a strong ability to generate profits from shareholder equity. The market capitalization of 220.71M EUR and a price-to-earnings (P/E) ratio of 12.12 suggest a relatively stable valuation. Other relevant KPIs to consider include debt-to-equity ratio, interest coverage ratio, and dividend yield, which can provide a more comprehensive understanding of the companys financial health and investment potential.
From a valuation perspective, Hydratec Industries NVs P/E ratio of 12.12 is relatively low compared to some of its peers in the Industrial Conglomerates sub-industry, potentially indicating undervaluation. However, a more detailed analysis of the companys financial statements, industry trends, and competitive landscape is necessary to determine its investment potential. Key metrics to monitor include revenue growth, margin expansion, and cash flow generation, which can help investors make informed decisions.
HYDRA Stock Overview
| Market Cap in USD | 248m |
| Sub-Industry | Industrial Conglomerates |
| IPO / Inception |
HYDRA Stock Ratings
| Growth Rating | 92.4% |
| Fundamental | 86.6% |
| Dividend Rating | 76.8% |
| Return 12m vs S&P 500 | 1.28% |
| Analyst Rating | - |
HYDRA Dividends
| Dividend Yield 12m | 3.66% |
| Yield on Cost 5y | 16.70% |
| Annual Growth 5y | 30.01% |
| Payout Consistency | 76.9% |
| Payout Ratio | 81.4% |
HYDRA Growth Ratios
| Growth Correlation 3m | -26.1% |
| Growth Correlation 12m | 89.3% |
| Growth Correlation 5y | 98.1% |
| CAGR 5y | 47.57% |
| CAGR/Max DD 5y | 1.74 |
| Sharpe Ratio 12m | -0.13 |
| Alpha | 16.25 |
| Beta | 0.517 |
| Volatility | 17.85% |
| Current Volume | 0.1k |
| Average Volume 20d | 0k |
| Stop Loss | 163.9 (-3%) |
| Signal | 2.03 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (31.6m TTM) > 0 and > 6% of Revenue (6% = 34.0m TTM) |
| FCFTA 0.12 (>2.0%) and ΔFCFTA 0.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 1.06% (prev 1.42%; Δ -0.36pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 48.2m > Net Income 31.6m (YES >=105%, WARN >=100%) |
| Net Debt (-1.42m) to EBITDA (65.6m) ratio: -0.02 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.06 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (NaN) change vs 12m ago NaN% (target <= -2.0% for YES) |
| Gross Margin 7.74% (prev 8.56%; Δ -0.82pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 247.8% (prev 107.1%; Δ 140.8pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 23.27 (EBITDA TTM 65.6m / Interest Expense TTM 1.88m) >= 6 (WARN >= 3) |
Altman Z'' 1.92
| (A) 0.03 = (Total Current Assets 98.8m - Total Current Liabilities 92.8m) / Total Assets 216.4m |
| (B) 0.08 = Retained Earnings (Balance) 18.2m / Total Assets 216.4m |
| (C) 0.19 = EBIT TTM 43.8m / Avg Total Assets 228.4m |
| (D) 0.16 = Book Value of Equity 18.2m / Total Liabilities 111.6m |
| Total Rating: 1.92 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.57
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 12.47% = 5.0 |
| 3. FCF Margin 4.66% = 1.16 |
| 4. Debt/Equity 0.07 = 2.50 |
| 5. Debt/Ebitda 0.12 = 2.49 |
| 6. ROIC - WACC 24.50% = 12.50 |
| 7. RoE 33.66% = 2.50 |
| 8. Rev. Trend 85.39% = 4.27 |
| 9. Rev. CAGR 15.37% = 1.92 |
| 10. EPS Trend 69.17% = 1.73 |
| 11. EPS CAGR 69.78% = 2.50 |
What is the price of HYDRA shares?
Over the past week, the price has changed by +1.20%, over one month by +3.05%, over three months by +2.42% and over the past year by +18.47%.
Is Hydratec Industries a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HYDRA is around 209.93 EUR . This means that HYDRA is currently undervalued and has a potential upside of +24.22% (Margin of Safety).
Is HYDRA a buy, sell or hold?
What are the forecasts/targets for the HYDRA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 232.7 | 37.7% |
HYDRA Fundamental Data Overview
Market Cap EUR = 212.9m (212.9m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 9.15m EUR (Cash only, last quarter)
P/E Trailing = 11.6892
P/S = 0.788
P/B = 2.0857
Beta = 0.57
Revenue TTM = 566.0m EUR
EBIT TTM = 43.8m EUR
EBITDA TTM = 65.6m EUR
Long Term Debt = 6.14m EUR (from longTermDebt, last quarter)
Short Term Debt = 1.59m EUR (from shortLongTermDebt, last quarter)
Debt = 7.73m EUR (Calculated: Short Term 1.59m + Long Term 6.14m)
Net Debt = -1.42m EUR (calculated as Total Debt 7.73m - CCE 9.15m)
Enterprise Value = 211.5m EUR (212.9m + Debt 7.73m - CCE 9.15m)
Interest Coverage Ratio = 23.27 (Ebit TTM 43.8m / Interest Expense TTM 1.88m)
FCF Yield = 12.47% (FCF TTM 26.4m / Enterprise Value 211.5m)
FCF Margin = 4.66% (FCF TTM 26.4m / Revenue TTM 566.0m)
Net Margin = 5.59% (Net Income TTM 31.6m / Revenue TTM 566.0m)
Gross Margin = 7.74% ((Revenue TTM 566.0m - Cost of Revenue TTM 522.2m) / Revenue TTM)
Tobins Q-Ratio = 11.61 (Enterprise Value 211.5m / Book Value Of Equity 18.2m)
Interest Expense / Debt = 6.82% (Interest Expense 527.0k / Debt 7.73m)
Taxrate = 24.15% (from quarterly Income Tax Expense: 3.67m / 15.2m)
NOPAT = 33.2m (EBIT 43.8m * (1 - 24.15%))
Current Ratio = 1.06 (Total Current Assets 98.8m / Total Current Liabilities 92.8m)
Debt / Equity = 0.07 (Debt 7.73m / last Quarter total Stockholder Equity 104.6m)
Debt / EBITDA = 0.12 (Net Debt -1.42m / EBITDA 65.6m)
Debt / FCF = 0.29 (Debt 7.73m / FCF TTM 26.4m)
Total Stockholder Equity = 93.9m (last 4 quarters mean)
RoA = 14.61% (Net Income 31.6m, Total Assets 216.4m )
RoE = 33.66% (Net Income TTM 31.6m / Total Stockholder Equity 93.9m)
RoCE = 43.78% (Ebit 43.8m / (Equity 93.9m + L.T.Debt 6.14m))
RoIC = 32.32% (NOPAT 33.2m / Invested Capital 102.8m)
WACC = 7.82% (E(212.9m)/V(220.7m) * Re(7.92%)) + (D(7.73m)/V(220.7m) * Rd(6.82%) * (1-Tc(0.24)))
Shares Correlation 5-Years: 100.0 | Cagr: 0.16%
Discount Rate = 7.92% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈27.0m ; Y1≈17.7m ; Y5≈8.10m
Fair Price DCF = 122.7 (DCF Value 159.3m / Shares Outstanding 1.30m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 85.39 | Revenue CAGR: 15.37%
Rev Growth-of-Growth: -29.37
EPS Correlation: 69.17 | EPS CAGR: 69.78%
EPS Growth-of-Growth: -98.50